French study maps scalp ringworm fungi and drug resistance
NCT ID NCT07631351
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at scalp ringworm, a common fungal infection in children, across 11 French centers in 2023. Researchers collected 701 fungal samples to identify the species and test their sensitivity to common antifungal drugs. The goal was to understand which fungi cause infections and whether resistance to treatments like terbinafine is emerging, helping guide future treatment choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose better treatments for scalp ringworm in children by understanding which fungi are common and whether they resist current drugs.
- What could go wrong
- This is an observational study, not a treatment trial. It describes the problem but does not test a new therapy, so direct patient benefits are not guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISOLATES OF DERMATOPHYTES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Parasitology-Mycology Department, Avicenne Hospital AP-HP,
Bobigny, Seine Saint Denis, 93009, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.